Search - Archive ouverte HAL Access content directly

Filter your results

33 Results

Immune Checkpoint Inhibitor–Associated Myositis

Céline Anquetil , Joe-Elie Salem , Bénédicte Lebrun-Vignes , Douglas Johnson , Andrew Mammen et al.
Circulation, 2018, 138 (7), pp.743-745. ⟨10.1161/CIRCULATIONAHA.118.035898⟩
Journal articles hal-03831164v1
Image document

Ultrasensitive Interferons quantification in idiopathic inflammatory myopathies serve as biomarkers of activity in dermatomyositis and anti-synthetase syndrome

Bolko Loïs , Celine Anquetil , Alba Llibre , Solene Maillard , Damien Amelin et al.
2021
Preprints, Working Papers, ... pasteur-03252308v1

Immune checkpoint inhibitor-associated myositis: a new entity amongst immune inflammatory myopathies with a poor prognosis

Céline Anquetil , Joe-Elie Salem , Bénédicte Lebrun-Vignes , Douglas Johnson , Andrew Mammen et al.
IFODS 2019, Jun 2019, Paris, France
Poster communications hal-03834301v1

Antigenic targets in anti-SRP immune-mediated necrotizing myopathy

Céline Anquetil , Nozomu Tawara , Maxime Lecerf , Damien Amelin , Alexandrine Mahoudeau et al.
4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic
Poster communications hal-03832564v1

Immune Checkpoint Inhibitor-Associated Myositis: A CharacteristicPhenotype with a Poor Outcome Related to Concomitant Myocarditis

Céline Anquetil , Joe-Elie Salem , Benedicte Lebrun-Vignes , Douglas B Johnson , Andrew Mammen et al.
American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. pp.1-3584, ⟨10.1002/art.40700⟩
Conference papers hal-03831343v1

Description of macrophages in idiopathic inflammatory myopathies using in-situ RNAseq

Julian Dal Cin , Céline Anquetil , Mehdi Touat , Lisa Salhi , Hossein Khademian et al.
4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic
Poster communications hal-03832557v1
Image document

MRI and muscle imaging for idiopathic inflammatory myopathies

Samuel Malartre , Damien Bachasson , Guillaume Mercy , Elissone Sarkis , Céline Anquetil et al.
Brain Pathology, 2021, 31 (3), pp.e12954. ⟨10.1111/bpa.12954⟩
Journal articles hal-03242994v1

IFN level assessed by ultrasensitive detection technology in myositis patient: A promising biomarker of disease activity in dermatomyositis and anti-synthetase syndrome

Loïs Bolko , Ségolène Toquet , Océane Landon-Cardinal , Karim Dorgham , Céline Anquetil et al.
American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. pp.1-3584, ⟨10.1002/art.40700⟩
Conference papers hal-03831328v1
Image document

Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database

Céline Anquetil , Joe-Elie Salem , Bénédicte Lebrun-Vignes , Sara Touhami , Anne-Claire Desbois et al.
Journal of Autoimmunity, 2020, 111, pp.102454. ⟨10.1016/j.jaut.2020.102454⟩
Journal articles hal-02948973v1
Image document

Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

Yves Allenbach , Céline Anquetil , Ali Manouchehri , Olivier Benveniste , Olivier Lambotte et al.
Autoimmunity Reviews, 2020, 19 (8), pp.102586. ⟨10.1016/j.autrev.2020.102586⟩
Journal articles hal-02948442v1

Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity

Alexandrine Mahoudeau , Céline Anquetil , Nozomu Tawara , Hossein Khademian , Damien Amelin et al.
Neuropathology and Applied Neurobiology, 2022, ⟨10.1111/nan.12849⟩
Journal articles hal-03830849v1

Evaluation of the effect of neutralizing anti-IFN-α antibodies produced in one SLE patient vaccinated with IFN-K on myotubes atrophy induced by type I interferon

Alexandrine Mahoudeau , Leandro Ladislau , Yves Allenbach , Thérèse Croughs , Allia Gati et al.
Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩
Poster communications hal-03832054v1
Image document

Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis

Mathilde Duchesne , Sarah Leonard‐louis , Océane Landon‐cardinal , Céline Anquetil , Kuberaka Mariampillai et al.
Brain Pathology, 2020, bpa.12844. ⟨10.1111/bpa.12844⟩
Journal articles hal-03523548v1

Myotoxicité liée aux inhibiteurs de points de contrôle immunitaire: trouble de l’appareil musculaire et/ou de la jonction neuromusculaire?

H. Chassepot , L. Plomp , S. Mensi , D. Psimaras , M. Touat et al.
83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A269, ⟨10.1016/j.revmed.2021.10.209⟩
Conference papers hal-03834073v1

Phénotype et pronostic des atteintes systémiques induites sous inhibiteurs de check-points immunitaires

C. Anquetil , J.E. Salem , A. Manouchehri , O. Lambotte , B. Lebrun-Vignes et al.
80ème congrès de la SNFMI, Dec 2019, Limoges, France
Conference papers hal-03834068v1

Rheumatic toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study

Céline Anquetil , Olivier Benveniste , Douglas Johnson , Bénédicte Lebrun-Vignes , Joe-Elie Salem et al.
American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2019, Nov 2019, Atlanta, United States. pp.1-5420, ⟨10.1002/art.41108⟩
Conference papers hal-03831676v1

Is early-onset primary Sjögren’s syndrome a worse prognosis form of the disease?

Céline Anquetil , Eric Hachulla , François Machuron , Xavier Mariette , Veronique Le Guern et al.
Journal articles hal-01965657v1

Dosage de l’interféron par technologie SIMOA au cours des myopathies inflammatoires idiopathiques : un biomarqueur diagnostique et d’activité

Yves Allenbach , L. Bolko , C. Anquetil , N. Wesner , D. Amelin et al.
78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩
Conference papers hal-03834002v1

Chronic disease course and ivig-dependance in long-term follow-up of anti-hmgcr immune-mediated necrotizing myopathy

Océane Landon-Cardinal , Kuberaka Mariampillai , Céline Anquetil , Aude Rigolet , Baptiste Hervier et al.
American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2019, Nov 2019, Atlanta, United States. 71 (S10), pp.1-5420, 2019, ⟨10.1002/art.41108⟩
Poster communications hal-03831692v1
Image document

Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy

Céline Anquetil , Olivier Boyer , Nadège Wesner , Olivier Benveniste , Yves Allenbach et al.
Autoimmunity Reviews, 2019, 18 (3), pp.223-230. ⟨10.1016/j.autrev.2018.09.008⟩
Journal articles hal-02377517v1

Toxicités sévères immuno-induites par les inhibiteurs de points de contrôle immunitaire : implications pour le réanimateur

Adam Celier , Yves Allenbach , Céline Anquetil , Fabrizio Andreelli , Anne Bachelot et al.
Médecine Intensive Réanimation, 2020, ⟨10.37051/mir-00046⟩
Journal articles hal-03832598v1
Image document

The role of interferons type I, II and III in myositis: A review

Loïs Bolko , Wei Jiang , Nozomu Tawara , Océane Landon-Cardinal , Céline Anquetil et al.
Brain Pathology, 2021, 31 (3), pp.e12955. ⟨10.1111/bpa.12955⟩
Journal articles hal-03242856v1

Précision diagnostique de l’électroneuromyogramme dans les myosites

L. Bolko , S. Louis-Leonard , L. Kanagaratnam , C. Pineau , C. Anquetil et al.
83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A265-A266, ⟨10.1016/j.revmed.2021.10.204⟩
Conference papers hal-03834082v1

immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication amongst rheumatic and musculoskeletal toxicities

Céline Anquetil , Olivier Benveniste , Javid J. Moslehi , Douglas B. Johnson , Bénédicte Lebrun-Vignes et al.
12th International congress on Autoimmunity virtual, May 2021, Athènes, Greece
Conference papers hal-03834293v1

Immune checkpoint inhibitor-associated myositis: a new entity with a poor prognosis

C. Anquetil , J. Salem , B. Lebrun-Vignes , D. Johnson , A. Mammen et al.
24th International Annual Congress of the World Muscle Society (WMS), Oct 2019, Copenhague, Denmark. pp.S121, ⟨10.1016/j.nmd.2019.06.301⟩
Conference papers hal-03832083v1

Immune checkpoint inhibitor-associated myositis: a new and severe entity amongst immune inflammatory myopathies

Céline Anquetil , Joe-Elie Salem , Bénédicte Lebrun-Vignes , Douglas B. Johnson , Andrew L. Mammen et al.
Global Conference on Myositis 2019 (GCOM 2019), Mar 2017, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩
Poster communications hal-03832066v1

Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance

Arthur Geraud , Paul Gougis , Aurore Vozy , Celine Anquetil , Yves Allenbach et al.
Annual Review of Pharmacology and Toxicology, 2021, 61 (1), ⟨10.1146/annurev-pharmtox-022820-093805⟩
Journal articles hal-02949235v1

Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI

C. Anquetil , S. Abdelhamid , A Gelis , Charles Fattal
Spinal Cord, 2016, 54 (11), pp.1031 - 1035. ⟨10.1038/sc.2016.49⟩
Journal articles hal-01869772v1

Immune checkpoint inhibitor-related myotoxicity : Musculoskeletal and/or neuromuscular junction disorder ?

Chassepot Hortense , Plomp Lotta , Psimaras Dimitri , Maisonobe Thierry , Plu Isabelle et al.
American College of Rheumatology Convergence, ACR 2021, Nov 2021, San Diego, United States. 73 (S9), pp.1-4259, 2021, ⟨10.1002/art.41966⟩
Poster communications hal-03831277v1

Myosites induites par les Inhibiteurs de Checkpoint Immunitaires : une nouvelle myopathie auto-immune associée à une atteinte myocardique de mauvais pronostic

C. Anquetil , J.E. Salem , B. Lebrun-Vignes , D.B. Johnson , A.L. Mammen et al.
78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩
Conference papers hal-03834040v1